ACCELERON PHARMA INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 23 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-08-30: Reporting owner MCLAUGHLIN KEVIN F; Form 4; Security Option to Purchase Common Stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-07-02: Reporting owner Zeldin Robert K; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-06-29: Reporting owner MCLAUGHLIN KEVIN F; Form 4; Security Option to Purchase Common Stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-05-10: Reporting owner Quisel John D; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-08-30 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,500 18,300 owned after | $27.97 exercise price | 2018-08-31 | |
| 2018-07-02 | Zeldin Robert K Officer (EVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +85,511 85,511 owned after | $47.33 exercise price | 2018-07-05 | |
| 2018-06-29 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 4,000 owned after | $24.11 exercise price | 2018-07-03 | |
| 2018-05-10 | Quisel John D Officer (EVP, CBO and Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $34.94 exercise price | 2018-05-11 | |
| 2018-03-21 | Maniatis Tom Director | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,750 0 owned after | $5.08 exercise price | 2018-03-23 | |
| 2018-03-06 | POPS RICHARD F Director | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −37,500 0 owned after | $5.08 exercise price | 2018-03-08 | |
| 2018-03-01 | Zakrzewski Joseph S Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $40.61 exercise price | 2018-03-05 | |
| 2018-03-01 | Smith Karen L. Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,875 1,875 owned after | $40.61 exercise price | 2018-03-05 | |
| 2018-03-01 | POPS RICHARD F Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $40.61 exercise price | 2018-03-05 | |
| 2018-03-01 | MCCOURT Thomas A Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $40.61 exercise price | 2018-03-05 | |
| 2018-03-01 | Maniatis Tom Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $40.61 exercise price | 2018-03-05 | |
| 2018-03-01 | Kearney Terrence C Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $40.61 exercise price | 2018-03-05 | |
| 2018-03-01 | George Jean Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $40.61 exercise price | 2018-03-05 | |
| 2018-03-01 | Nader Francois Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $40.61 exercise price | 2018-03-05 | |
| 2018-03-01 | Kumar Ravindra Officer (SVP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +26,775 26,775 owned after | $40.61 exercise price | 2018-03-05 | |
| 2018-03-01 | Rovaldi Christopher Officer (SVP, Program Mgmt and Ops) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,375 24,375 owned after | $40.61 exercise price | 2018-03-05 | |
| 2018-03-01 | KANGO SUJAY Officer (SVP, Chief Commercial Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $40.61 exercise price | 2018-03-05 | |
| 2018-03-01 | Quisel John D Officer (SVP, Corp. Dev., GC & Sec.) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,950 28,950 owned after | $40.61 exercise price | 2018-03-05 | |
| 2018-03-01 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,825 30,825 owned after | $40.61 exercise price | 2018-03-05 | |
| 2018-03-01 | Dable Habib J Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +108,800 108,800 owned after | $40.61 exercise price | 2018-03-05 | |
| 2018-01-12 | Rovaldi Christopher Officer (SVP, Program Mgmt and Ops) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,000 12,000 owned after | $24.11 exercise price | 2018-01-17 | |
| 2018-01-03 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,251 0 owned after | $3.88 exercise price | 2018-01-04 | |
| 2018-01-03 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,250 0 owned after | $5.28 exercise price | 2018-01-04 |